โข
DX
DXCM
DexCom, Inc.
yahooSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
--
Price Chart
Market Cap
28.12B
Volume
5.41M
52W High
$93.25
52W Low
$54.11
Open
$0.00
Prev Close
$70.73
Day Range
0.00 - 0.00
About DexCom, Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Latest News
DexCom, Inc. Sued for Securities Law Violations โ Investors Should Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights โ DXCM
GlobeNewswire Inc.โขDec 26
DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm
GlobeNewswire Inc.โขDec 26
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
GlobeNewswire Inc.โขDec 26
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc.โขDec 23
DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm
GlobeNewswire Inc.โขDec 23
DexCom, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit
GlobeNewswire Inc.โขDec 16
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DexCom and CarMax and Encourages Investors to Contact the Firm
GlobeNewswire Inc.โขDec 16
DXCM DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important December 29 Deadline in Securities Class Action โ DXCM
GlobeNewswire Inc.โขDec 16